- Home
- Publications
- Publication Search
- Publication Details
Title
Pediatric Dosing and Body Size in Biotherapeutics
Authors
Keywords
-
Journal
Pharmaceutics
Volume 2, Issue 4, Pages 389-418
Publisher
MDPI AG
Online
2010-12-18
DOI
10.3390/pharmaceutics2040389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, single-blind, dose-escalation, crossover study
- (2009) Jaret Malloy et al. CLINICAL THERAPEUTICS
- Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
- (2009) Brian J. Anderson et al. Drug Metabolism and Pharmacokinetics
- Pharmacokinetics and dose requirements of factor VIII over the age range 3–74 years
- (2009) Sven Björkman et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Inhaled Growth Hormone (GH) Compared with Subcutaneous GH in Children with GH Deficiency: Pharmacokinetics, Pharmacodynamics, and Safety
- (2009) Emily C. Walvoord et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Consortium
- (2009) Tanya M. Trippett et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report
- (2009) Anne L. Angiolillo et al. PEDIATRIC BLOOD & CANCER
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency
- (2008) Ferenc Peter et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study
- (2008) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- Population Pharmacokinetic Modeling of Epoetin Delta in Pediatric Patients With Chronic Kidney Disease
- (2008) William Knebel et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease
- (2008) Jane C. Burns et al. JOURNAL OF PEDIATRICS
- Plasma and albumin-free recombinant factorVIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients
- (2008) V. S. BLANCHETTE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial*
- (2008) Thomas Danne et al. PEDIATRIC DIABETES
- Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned
- (2008) W. Rodriguez et al. PEDIATRICS
- Pharmacokinetics and Immunodynamics of Basiliximab in Pediatric Renal Transplant Recipients on Mycophenolate Mofetil Comedication
- (2008) Britta Höcker et al. TRANSPLANTATION
- Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
- (2007) B.J. Anderson et al. Annual Review of Pharmacology and Toxicology
- Overview of the human pharmacokinetics of recombinant activated factor VII
- (2007) Thomas Klitgaard et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients
- (2007) Mark D. Pescovitz et al. PEDIATRIC TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started